Treatment of pharmaceutical wastewater containing tylosin in an anaerobic-anaerobic reactor system by Chelliapan, Shreeshivadasan et al.
Water Practice & Technology Vol 5 No 1 © IWA Publishing 2010 doi: 10.2166/WPT.2010.016 
 
Treatment of Pharmaceutical Wastewater Containing Tylosin in an 
Anaerobic – Aerobic Reactor System 
 
Shreeshivadasan Chelliapan1, Thomas Wilby2  and Paul Sallis3 
1Senior Lecturer/Head of Department, Department of Civil Engineering, College of Science and 
Technology (CST), University Technology Malaysia, (International Campus), 54100, Kuala Lumpur, 
Malaysia. Tel: 006-03-26154404; Fax: 006-03-26934844; E-mail: shreeshivadasan@ic.utm.my  
2Senior Engineer, Eli Lilly and Company Limited, Speke, Liverpool L24 9LN, UK. 
3Senior Lecturer, Environmental Engineering Group, School of Civil Engineering and Geosciences, 
University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU, UK.  
 
Abstract: Effluents from manufacturing operations in the pharmaceutical industry, such as antibiotic 
formulation, usually contain recalcitrant compounds. An approach towards appropriate technology for the 
treatment of pharmaceutical wastewaters has become imperative due to strict water quality legislation for 
environmental protection. In the present study, an Up-Flow Anaerobic Stage Reactor (UASR) and a Porous 
Membrane Activated Sludge Reactor (PMASR), operating in series, were used to treat pharmaceutical 
wastewater containing the macrolide antibiotic Tylosin. The performance of UASR treating real 
pharmaceutical wastewater at various organic loading rates (OLR) (0.43 to 3.73 kg COD.m–3.d–1) was 
investigated. Effluent from the UASR was passed directly into a PMASR system in a continuous process. At a 
reactor OLR of 1.86 kg COD.m–3.d–1 (hydraulic retention time (HRT), 4 d), the soluble COD reduction was 
around 70 - 75% (average specific degradation rate (SDR), 1.29 kg COD.m–3.d–1 ) an average of 95% Tylosin 
reduction was achieved in the UASR. During this period, the soluble COD removal efficiency of the PMASR 
was 63–69% (average SDR, 0.37 kg COD.m–3.d–1). The combined UASR – PMASR treatment system was 
slightly more effective with 87–90% COD and average 97% Tylosin removal. The results indicate successful 
treatment of the pharmaceutical wastewater, and confirm Tylosin degradation, providing further evidence that 
Tylosin can be degraded efficiently in anaerobic-aerobic environments.  
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1. Introduction 
Wastewaters produced from pharmaceutical industries, such as antibiotic manufacture and 
formulation, generally contain high levels of soluble organics, many of which are 
recalcitrant (Schroder, 1999). If these compounds are not removed by one-site treatment 
they will be discharged to sewage treatment plants (STPs) where they may disturb the 
biological process and the microbial ecology, and potentially affect receiving surface 
waters. Typically, pharmaceutical wastewater is characterized by high COD concentration, 
some pharmaceutical wastewaters having a COD as high as 80,000 mg.L–1 (Nandy and 
Kaul, 2001). Most published studies have investigated the removal of COD but ignored 
antibiotic removal during treatment. Although high COD removal efficiencies have been 
achieved, biological treatment is sometimes ineffective in the removal of antibiotics under 
some circumstances (Adams et al. 2002; Saravanane et al. 2001b). It is therefore important 
to investigate antibiotic degradation associated with COD removal in wastewater treatment 
processes.  
  For industrial wastewater treatment, an anaerobic process is often applied to reduce of the 
major part of the COD load, which is then followed by an aerobic treatment to oxidize the 
residual COD in the wastewater. This is because effluent from the anaerobic bioreactor 
usually has substantial amounts of residual COD even if its removal efficiency is above 
90% (Zhou et al. 2006). Therefore, direct discharge to the environment immediately after 
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anaerobic treatment is rarely permitted, and post-treatment by an aerobic process is usually 
necessary. According to Field et al. (1995), an aerobic polishing step was required for 
complete mineralisation of aromatic amines and chlorinated aromatics treated by anaerobic 
digestion. In addition, process optimisation can be achieved by the use of a sequential 
anaerobic-aerobic treatment system, particularly when treating highly recalcitrant 
wastewaters (van Lier et al. 2001). Despite these considerations, there is a limited number 
of experimental studies investigating the treatment of pharmaceutical wastewaters in an 
anaerobic-aerobic reactor systems (Fox and Venkatasubbiah (1996); Buitrón et al. (2003); 
Zhou et al. (2006); Sponza and Demirden (2007). 
  Tylosin is a macrolide antibiotic produced by a strain of Streptomyces fradiae. It has good 
anti-bacterial activity against most pathogenic gram-positive bacteria, and some gram-
negative bacteria, vibrio, spirochete, coccidian, etc. It is one of the first-choice drugs 
against infections caused by mycoplasma. The chemical structure of Tylosin is given in 
Figure 1. 
  The aim of this study was to investigate treatment of pharmaceutical wastewater that 
contains Tylosin in a sequential Up-Flow Anaerobic Stage Reactor (UASR) and Porous 
Membrane Activated Sludge Reactor (PMASR). The more specific objectives of this 
research were to assess the stability of reactor for measured parameters (e.g. COD and TOC 
removal) and to investigate the efficiency of Tylosin reduction in the UASR-PMASR 
system. To date, there is no reported study on the treatment of pharmaceutical wastewater 
containing macrolide Tylosin by a sequential anaerobic–aerobic reactor system. 
 
 
Figure 1: Chemical structure of Tylosin. 
 
2. Materials and methods 
2.1 Reactor configurations 
A continuously fed laboratory scale UASR and a PMASR, operating in series, were used in 
this study. The operational set-up, flow diagram and reactor design are presented in  
Figure 2a. The UASR system comprise four identical cylindrical Plexiglas compartments 
(stages), 80 mm internal diameter by 640 mm height, linked in series and was developed 
according to the concept of Anaerobic Baffled Reactor (ABR) (Barber and Stuckey, 1999). 
The active volume of the UASR system was 11 L (4 stages of 2.75 L). Each stage of the 
reactor had a 3-phase separator baffle, angled at 45o and placed 50 mm below the effluent 
ports, to prevent floating granules from washing out with the effluent (Figure 2b). Each 
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stage was equipped with sampling ports at 100 mm intervals (lowest being 30 mm from the 
base) that allowed biological solids and liquid samples to be withdrawn from the sludge 
bed. The influent wastewater entered through a 12 mm internal diameter downcomer tube 
in the headplate that extended to within 15 mm of the reactor base and allowed feed to flow 
upward through the sludge bed. Effluent from each stage of the reactor flowed by gravity to 
the next, as each stage was placed on stepped platform having a 150 mm step height. The 
walls of the reactors were wrapped with a tubular polyvinyl chloride (PVC) water-jacket 
with 15 mm internal diameter, to maintain the reactor temperature at 37°C. Peristaltic 
pumps (Watson Marlow 100 series) were used to control the influent feed rate to the first 
stage of the UASR. Effluent from the UASR flowed to a PMASR for aerobic treatment. 
The aerobic reactor was cylindrical, 400 mm high and 155 mm diameter with an 
operational volume of 4.1 litres. It included a porous membrane 316 mm high and 145 mm 
diameter made from a polymer material (high density polyethylene, HDPE) with a wall 
thickness of 3.5 mm and nominal pore size of 5–8 µm which acted as a secondary clarifier. 
Watson Marlow 500 series peristaltic pump was used to supply the feed to the PMASR.  
Aeration was provided approximately 3 L.min–1 from the laboratory compressed air supply 
through a standard aquarium diffuser stone located at the base of the reactor. The dissolved 
oxygen (DO) concentration was monitored and air flow regulated in order to maintain a 
minimum DO concentration of  2 mg.L–1 at all times.  
 
2.2 Pharmaceutical wastewater 
The pharmaceutical wastewater was supplied by Eli Lilly & Company Ltd, Liverpool, UK 
and had the following characteristics; soluble COD, 7000 ± 800 mg.L–1; soluble BOD5, 
3500 ± 500 mg.L–1; sulphate, 2500 ± 500 mg.L–1; Total Kjeldahl Nitrogen (TKN), 364 ± 50 
mg.L–1; pH, 5.2–6.8; and Tylosin concentration, 20 to 200 mg.L–1.  
 
2.3 Reactor operation 
In general, the operation of UASR was carried out in five major steps (Table 1): start-up of 
UASR, acclimatisation to pharmaceutical wastewater, step increase in OLR (0.43–1.86 kg 
COD.m–3.d–1) by altering feed COD (1700 – 7450 mg.L–1) at constant HRT (4 d), and then 
further step increments in OLR to 3.73 kg COD.m-3.d–1 by reducing the HRT from 4 to 2 d 
at constant feed COD (7450 mg.L–1). Finally, the OLR was reduced again to 1.86 kg  
COD.m–3.d–1 (HRT 4 d) to determine the ability of the reactor to recover treatment 
efficiency (Table 1). The UASR was seeded with anaerobic digested sewage sludge from 
an anaerobic sludge digester at Hexham Municipal sewage treatment plant, 
Northumberland, UK. Effluent from the UASR was passed through a PMASR reactor after 
the UASR performance had approached steady-state at an OLR of 1.86 kg COD.m–3.d–1. 
Cramlington municipal wastewater treatment plant, Northumberland, UK, giving an initial 
mixed liquor suspended solids (MLSS) concentration of 2500 mg.L–1. The reactor was then 
conditioned by feeding brewery wastewater (selected for ease of degradation, high COD 
value, and having well established use in continuous anaerobic reactors, Sallis and Uyanik, 
2003) as substrate, at flow rate of 1 L.d–1 (HRT of 4 d), the feed COD concentration being 
maintained between 500 and 1500 mg.L–1. MLSS concentration was monitored in 
particular during the start up phase to understand the aerobic biomass growth kinetics in the 
reactor.  
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Figure 2a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2b. 
 
Figure 2: (a) Experimental set-up and flow chart of UASR-PMASR; (b) details of an individual 
UASR stage. 
 
  After PMASR start-up on brewery wastewater feed, sludge was acclimated to UASR 
effluent gradually (i.e. the UASR effluent was blended with brewery wastewater in 
increasing proportions, stepwise from 20 to 100% (as COD), with corresponding reductions 
in the brewery wastewater component). This achieved successful acclimatisation of 
biomass to the partially treated pharmaceutical wastewater components during the sensitive 
Feed Tank 
Peristaltic 
pump 
Stage 1 
Stage 2 
Stage 3 
Stage 4 
Effluent 
Gas flow measurement 
Feed Tank (Effluent 
from UASR) 
Peristalti
c Pump
Collection 
Tank 
Effluen
Porous 
Membrane 
Air 
Drainage / 
Excess Sludge 
(C) 
Porous Membrane Activated Sludge Reactor 
Up-Flow Anaerobic Stage Reactor
Sampling 
Ports 
Effluent 
Liquid level 
Influent 
3-phase  
separator  
baffle 
Gas flow  
measurement 
Thermometer 
5 
start-up period by creating conditions of minimal organic load and hydraulic stresses. The 
reactor was aerated continuously, and pH was maintained in the range of 7.0–8.2 by 
adjustment of the feed pH with NaOH. Nutrient levels were maintained in the ratio of COD: 
N: P at 100:5:1 (Metcalf and Eddy, 2003).  The biomass was considered to be acclimatised 
when MLSS concentration maintained constant levels (3000 ± 200 mg.L–1). During the 
course of the investigation, a small problem developed from foaming in this reactor, 
probably due to surfactant chemicals in the pharmaceutical wastewater. This was controlled 
by addition of an antifoaming agent (Silicone Antifoaming Agent, BDH Laboratory 
Supplies, UK; Product Code 512K), which did not appear to inhibit the biomass activity.  
 
Table 1: Summary of reactor operating conditions of UASR system 
________________________________________________________________________________________ 
 
Step Brewery (%)* Antibiotic (%)* Mean OLR  HRT  Mean Feed COD      Day  
wastewater  wastewater  (kg COD.m–3.d–1)   (d) (mg.L–1) 
________________________________________________________________________________________ 
 
1 100 – 50  0 – 50  0.43   4.0 1700        – 
________________________________________________________________________________________ 
 
2 50  50  0.43   4.0 1700        1 
3 40 – 10  60 – 90  0.86   4.0 3450        41 
 0  100  1.23   4.0 4900        82 
0  100  1.53   4.0 6100        109 
0  100  1.86   4.0 7450        166 
4 0  100  2.48   3.0 7450        188 
0  100  2.98   2.5 7450        212 
0  100  3.73   2.0 7450        231 
5 0  100  1.86   4.0 7450        250 
________________________________________________________________________________________
*proportion based on COD. 
 
2.4 Analytical methods 
Sample analysis included chemical oxygen demand (COD), total organic carbon (TOC), 
pH, alkalinity, suspended solids (SS), volatile suspended solids (VSS), all according to 
Standard Methods (APHA, 1998). Available PO4-P was determined by ion-chromatography 
(Dionex, DX-100 Ion Chromatograph), volatile fatty acids (VFA) by gas-liquid 
chromatography (Unicam 610 Series Gas Chromatograph with auto-injector and PU 4811 
computing integrator) having operating conditions as follows: carrier gas: nitrogen at  
20 ml.min–1; column temperature 140 C; detector temperature: 180 C; injection port 
temperature: 180 C; column dimensions: 2000 mm long x 2 mm I.D. glass packed with 
10% AT-1000 on 80/100 Chromosorb W-AW; detector type: flame ionisation detector. 
TOC measurement was based on quantitative infrared analysis performed with a Total 
Organic Carbon Analyser (Shimadzu Model, TOC-5050A). Reactor gas composition (CO2 
and CH4) was determined by gas chromatography (Becker model 403 Gas Chromatograph 
with Unicam 4815 computing integrator) under the following operating conditions; carrier 
gas: helium at 50 ml.min–1, column temperature 55 C, metal column dimensions: 2000 mm 
long x 4mm I.D. packed with Porapak Q, detector: thermal conductivity. 
6 
  Average values of the measured parameters quoted for each OLR were based on the mean 
of four data points taken after three HRT periods for each OLR, i.e. when reactor 
approached near steady-state. 
 
2.5 Tylosin Assay 
Tylosin assay was performed by HPLC on a 20cm Nucleosil C18 analytical column eluted 
with 60 vols 2 mol.dm–3 sodium perchlorate (NaClO4) and 40 vols of acetronitrile 
(CH3CN). Tylosin factors were separated and detected at 280nm. The integrated 
chromatogram was normalised and the relative percentage of each Tylosin factor reported. 
Comparison of each Tylosin sample chromatogram with that of a Tylosin base reference 
standard chromatogram confirmed peak identity for quantification against a 3-point 
standard curve.  
 
3. Results and discussion 
3.1 UASR performance 
During start-up, the UASR showed steady-state COD conversion efficiencies of 93%, and 
no substantial reductions in the COD removal efficiency when reactor feed was 
supplemented incrementally with pharmaceutical wastewater (Table 2). The preliminary 
phase (acclimatisation) confirmed that the methanogenic activity in the UASR could be 
maintained in the presence of pharmaceutical wastewater (total methane production was 
1150 ml.d–1, Table 2). Table 3 shows the pH levels in the UASR treating pharmaceutical 
wastewater when the OLR was increased gradually. The pH levels were generally  
stable (pH 6.3–7.8) in all stages of the UASR until the reactor OLR exceeded 2.98 kg 
COD.m–3.d–1. Consequently, at a reactor OLR of 3.73 kg COD.m–3.d–1 (when the reactor 
HRT was reduced to 2 d) the pH in Stage 1 dropped to 5.7 due to the rapid production of 
VFAs resulting from increased acidogenic activity. At the same time, pH reduction was 
also observed in all subsequent reactor stages; the degree of pH reduction following the 
order Stage 1>2>3>4 which reflected the actual OLR of each stage (stage OLR followed 
the order 1>2>3>4 on account of the sequential degradation of the influent COD load as it 
passed through the reactor system; e.g. at a reactor OLR of 3.73 kg COD.m–3.d–1 the actual 
OLR in Stage 1 was 14.92 kg COD.m–3.d–1, while actual OLR in Stage 4 was 1.75 kg 
COD.m–3.d–1). However, when the reactor OLR was reduced back to 1.86 kg COD.m–3.d–1, 
the pH in Stage 1 stabilised at 7.2 indicating that acidogenesis and methanogenesis had 
recovered balanced levels. From the pH data, it can be assumed that the metabolic 
processes differed between Stages 1 to 4 of the UASR system (particularly when OLR 
exceeded 2.48 kg COD.m-3.d-1) and this would cause each stage to favour a unique 
population of microorganisms.  
  The total VFA concentration in each stage of the reactor is shown in Table 3 and indicates 
a low  concentration of total VFA (average 222 mg.L-1) was present in the reactor effluent 
(Stage 4) when operated at OLR in the range 0.43 to 1.53 kg COD.m-3.d-1 (4 d HRT). 
However, the effluent VFA concentration increased to 949 mg.L-1 when the reactor  
OLR was increased to 2.48 kg COD.m-3.d-1. Further increases in reactor OLR, by reducing 
the HRT, resulted in higher VFA concentrations being produced in the effluent. The highest 
of these was found when OLR was 3.73 kg COD.m-3.d-1 with an average value of  
3,310 mg.L-1 in Stage 1, 2,311 mg.L-1 in Stage 2, 1,522 mg.L-1 in Stage 3 and 1,468 in 
Stage 4. At high OLRs and low HRTs the relatively complex pharmaceutical wastewater 
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caused pre-acidification resulting in accumulation of COD (as VFA), which did not 
subsequently convert to methane, resulting in an accumulation of VFA. However, when the 
reactor OLR was reduced to 1.86 kg COD.m-3.d-1, recovery was almost immediate with the 
effluent VFA concentration being 280 mg.L-1. The ability of the reactor to recover rapidly 
when OLR was returned to 1.86 kg COD.m-3.d-1 follows a similar pattern to that found in 
the COD (Figure 3) and pH levels, however, complete recovery of COD removal efficiency 
required more time than pH and VFA recovery. 
 
Table 2: Summary of UASR performance during start-up and acclimatisation to pharmaceutical 
wastewater (average values when reactor approached steady-state). 
Source Parameter  Start-up   Acclimatisation  
    (OLR 0.43 kg COD.m–3.d–1  (OLR 0.43 kg COD.m–3.d–1  
    and HRT 4d)   and HRT 4 d) 
Influent  COD (mg.L–1)  1700 (mg.L–1)   1700 (mg.L–1) 
  pH   7.2    7.2 
 
Effluent  COD (mg.L–1)  119 (mg.L–1)   221 (mg.L–1) 
  COD removal (%) 93%    87% 
  pH   7.6    7.7 
  VFA   100 (mg.L–1)   130 (mg.L–1) 
  Methane production 1350 (ml.d–1)   1150 (ml.d–1) 
 
  Biogas production was monitored in all stages throughout the operation of the reactor, 
particularly for the assessment of methanogenic activity. Table 3 shows the methane 
volume produced in each stage of the reactor system. It is evident that Stage 1 produced the 
greatest volume of methane when the reactor OLR was operating between 0.43–1.86 kg 
COD.m-3.d-1. However, at higher OLR (2.48 COD.m-3.d-1), the methane production in Stage 
1 dropped dramatically from an average value of 3432 ml.d-1 (at OLR 1.86 COD.m-3.d-1 ) to 
1066 ml.d-1, and this reduced further to 671 and 269 ml.d-1 when the reactor was operated 
at OLR 2.98 and 3.73 COD.m-3.d-1, respectively. Considering the changes in pH, and VFA 
concentration, that occurred with these step increases in OLR (Table 3) it is likely that a 
large part of the methanogenic population was adversely affected by physico-chemical 
conditions created by the acidogens at higher OLR. However, this inhibitory effect was not 
permanent, and methane production in Stage 1 of the reactor system recovered to 3127 
ml.d-1 when the reactor OLR was reduced back to 1.86 kg COD.m-3.d-1. During the period 
of reduced methane productivity in Stage 1 (i.e at OLR 2.48 to 3.73 kg COD.m-3.d-1), 
Stages 3 and 4 each showed relatively higher levels of methane production compared to 
that at lower OLR, but this returned to previous levels when the OLR was reduced to 1.86 
kg COD.m-3.d-1.  In contrast, Stage 2 showed relatively constant levels of methane 
production over a wide range of OLR (1.86 to 3.73 kg COD.m-3.d-1). 
  Figure 3 shows temporal changes in the COD removal of the UASR treating 
pharmaceutical wastewater when the OLR was increased gradually. Initial fluctuations 
were attributed to technical problems with the peristaltic feed pump. At a reactor OLR of 
1.86 kg COD.m-3.d-1 (HRT 4 d), the soluble COD reduction was around 70–75% (average 
SDR being 1.29 kg COD.m-3.d-1, Figure 4). However, when the OLR was increased to 2.48 
kg COD.m-3.d-1 (by lowering the HRT, since the strength of the wastewater was limited) the 
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Table 3: Typical pH, VFA and methane production in UASR stages at different OLR (average 
values when reactor approached steady-state). 
 
 
OLR (kg COD.m-3.d-1) 
 
UASR Parameter  0.43 0.86 1.23 1.53 1.86 2.48 2.98 3.73 1.86 
Stages 
 
pH  7.07 7.03 6.97 7.17 7.11 6.81 6.26 5.66 7.20 
Stage 1 VFA (mg.L-1) 586 287 783 477 702 2410 3313 3310 823  
 Methane (ml.d-1) 791 1497 2170 2697 3432 1066 671 269 3127  
 
 
pH  7.20 7.15 7.17 7.36 7.38 7.20 6.98 6.36 7.18  
Stage 2 VFA (mg.L-1) 356 154 645 451 593 1589 2276 2311 634 
Methane (ml.d-1) 414 437 469 796 1384 1532 1504 1359 1492 
 
pH  7.31 7.26 7.32 7.55 7.58 7.55 7.15 6.78 7.24 
Stage 3 VFA (mg.L-1) 260 127 390 425 340 708 945 1522 400 
 Methane (ml.d-1) 313 264 363 343 195 762 1063 1675 525 
 
 
pH  7.83 7.57 7.78 7.84 7.84 7.77 7.41 6.94 7.80  
Stage 4 VFA (mg.L-1) 199 65 250 374 250 949 1127 1468 280 
Methane (ml.d-1) 184 128 320 291 228 606 925 775 358 
 
 
 
 
Figure 3: COD and TOC reduction profile of UASR at different OLR. 
 
COD removal efficiency decreased gradually until only around 45% soluble COD removal 
(average removal when reactor approached steady-state) was observed at an OLR of  
3.73 kg COD.m-3.d-1 (SDR being 1.48 kg COD.m-3.d-1, Figure 4). The above results are 
consistent with observations made by Rodríguez-Martinez et al. (2005) in an UASB 
treating pharmaceutical wastewater containing Penicillin G macrolide antibiotics, who 
found that the COD removal efficiency was 90% at an OLR of 1.5 kg COD.m-3.d-1 and 
HRT 11 d. However, when the OLR was increased to 2.09 kg COD.m-3.d-1 by reducing the 
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HRT to 7 d, the COD removal efficiency dropped substantially to 70%. They also found 
that an increase in the OLR resulted in the accumulation of hydrogen sulphide in the biogas 
(sulphate in the feed was 3200 mg.L-1) which affected the efficiency of the reactor; the 
presence of sulphide is known to inhibit the activity of methanogens (McCartney and 
Oleszkiewicz, 1991). It is generally known the application of anaerobic treatment processes 
for industrial wastewaters containing high amounts of sulphate has been problematic due to 
the production of hydrogen sulphide. The presence of H2S in anaerobic digesters results 
from the action of sulphate-reducing bacteria (SRB) which utilise sulphate as terminal 
electron acceptor and compete with acetogens and methanogens for several key substrates 
in anaerobic digestion such as propionate, butyrate, ethanol and acetate (Oude-Elferink  
et al. 1994). Moreover, SRB are generally expected to out-compete other anaerobes in the 
presence of excess sulphate (O'Flaherty et al. 1998). The pharmaceutical wastewater used 
in this study also contained high concentration of sulphate (2500 ± 500 mg.L-1) and 
sulphide production from this sulphate was thought to be one of the reasons for the poor 
performance of UASR during the period of high OLR (2.48–3.73 kg COD.m-3.d-1). Speece, 
1996 has stated that at higher OLR, SRB have a competitive advantage over methanogens 
for substrates, and it is possible for hydrogen sulphide production to predominate over 
methane gas production. Fox and Venkatasubbiah (1996) reported that as influent 
pharmaceutical wastewater containing high sulphate was increased to 20% in an ABR, the 
reactor performance deteriorated (COD removal efficiency reduced from 50 to 20%) as the 
effluent sulphide concentration increased to inhibitory levels (more than 200 mg.L-1). 
Kuscu and Sponza (2006) have demonstrated that hydrogen sulphide concentrations in the 
biogas increased from 160 ppm to 195 ppm when OLR was increased from 2.1 to 3.16 kg 
COD.m-3.d-1 in an ABR treating sulphate-containing wastewater (p-Nitrophenol). 
Consequently, it was thought that as OLR was increased (2.48–3.73 kg COD.m-3.d-1) in the 
UASR, the increasing load of Tylosin and sulphide production affected the methanogens, 
therefore, contributing to the lower process efficiency of the system. Another important 
point is that changes in HRT may have affected the operation of the UASR (increasing the 
OLRs to 3.73 kg COD.m-3.d-1 by reducing the HRT (4–2 d) reduced the COD removal 
efficiency to 45%). When the OLR was increased, the increasing acidogenic activity 
usually results in lower pH values; reduced methanogenic activity; increased COD and 
VFA in the effluent of the UASR. Even though it was expected that the UASR would be 
stable at high OLRs, it was not able to withstand the short HRT, probably due to the 
complexity of pharmaceutical wastewater which contained Tylosin and sulphate. In general, 
longer HRT can help the kinetics of degradation, i.e. more complex organics like polymers 
and recalcitrant simply have longer to be degraded. Nandy and Kaul (2001) have 
demonstrated that substrate removal efficiency increases with increase in HRT in anaerobic 
treatment of herbal-based pharmaceutical wastewater using fixed-bed reactor. Zhou et al. 
(2006) reported that when HRT of an ABR treating pharmaceutical wastewater containing 
antibiotics (Ampicillin and Aureomycin) was extended from 1.25 to 2.5 d, the COD 
removal efficiency increased from 77 to 85%. They also observed that the antibiotic 
removal efficiencies increased from 16 to 42% for Ampicillin and 26 to 31% for 
Aureomycin.    
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Figure 4: Specific degradation rate (SDR) profile of UASR at different OLR. 
 
  The organic content of the reactor feed and effluent was determined by measurement of 
the total organic carbon (TOC). The profile of TOC removal throughout the operation 
period was consistent with that of COD removal (Figure 3). Another factor associated with 
sulphate reduction (data not presented) is the fact that leads to the underestimation of 
organic matter degradation when this based on COD values because sulphide is oxidised 
during the COD test. Consequently, if there is large quantity of sulphide ions in the effluent, 
there will be a difference in the TOC and COD removal pattern. In the present study, the 
difference in COD and TOC removal profile was small (Figure 3), confirming that most 
sulphide partitions into the biogas (exchange between soluble sulphide and gaseous 
hydrogen sulphide being pH dependent). This is further supported by low levels of sulphide 
ion detected in the effluent of UASR (spot data of sulphide ion in UASR effluent showed 
10–40 mg.L-1 for all OLR investigated). 
 
3.2 UASR-PMASR performances 
Generally, an anaerobic process is applied to remove high concentrations of organic matter 
followed by an aerobic treatment to oxidise the residual organic matter. Given that influent 
COD is very high, effluent from anaerobic reactor can still have residual COD. 
Consequently, direct discharge of effluent from anaerobic reactor is not permitted, and 
post-treatment of anaerobic process effluent with an aerobic reactor is necessary. The 
effluent from UASR was further subjected to aerobic treatment (PMASR) to remove the 
residual COD. Figure 5 shows the results of COD and TOC removal from the UASR 
effluent by the PMASR during periods when the UASR was had an OLR above 1.86 kg 
COD.m-3.d-1. As a result, the feed to the PMASR contained variable influent COD values, 
caused by the different OLRs applied to the UASR. During the reactor start-up period with 
brewery wastewater (total duration was 21 days), the COD removal efficiency of the 
PMASR was around 89% (Figure 5), after which point the COD removal efficiency 
dropped to 76% when the reactor was being acclimated gradually to effluent from UASR. 
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From day 52, the PMASR was operated with 100% effluent from the UASR, and an HRT 
of 4 d. This led to a soluble COD removal efficiency for the PMASR of 63–69% (SDR 
being 0.37 kg COD.m-3.d-1, Figure 6). During this period, effluent from UASR contained 
1800-2200 mg.L-1 of COD (UASR operating at OLR of 1.86 kg COD.m-3.d-1). However, 
the COD removal efficiency dropped noticeably to an average 51% (SDR being 0.42 kg 
COD.m-3.d-1, Figure 6) during the period of high OLR in the UASR (2.48–3.73 kg COD. 
m-3.d-1), and recovered to around 66% (SDR being 0.38 kg COD.m-3.d-1, Figure 6) when 
the UASR was returned to an OLR of 1.86 kg COD.m-3.d-1. Changes in HRT of the UASR 
may have affected the aerobic biodegradation rate in the PMASR. When the PMASR was 
fed with anaerobic effluent from the UASR that operated with HRT of 4 d, the residual 
COD from the PMASR was stabilised at700 mg.L-1, indicating substantial amount of COD 
that remained in the UASR effluent could be removed aerobically. However, when the 
HRT of the UASR was reduced from 4 to 2 d, significant changes occurred in the PMASR 
effluent (residual COD was 1000 mg.L-1 when the OLR was 2.48–3.73 kg COD.m-3.d-1). 
Moreover, due to the nature of the pharmaceutical wastewater used in this study, a fraction 
of the wastewater is nonbiodegradabale under aerobic condition and complete removal of 
substrate cannot be expected due to the presence of the refractory material that could not be 
destroyed aerobically (Zhou et al. 2006). It is generally known that longer anaerobic 
treatment time could result in a decrease in the fraction of refractory organic materials since 
some refractory fraction under aerobic conditions could be decomposed at the acidogenic 
stage and some intermediates could be generated. These intermediates were more readily 
degraded under aerobic conditions.  
  The TOC removal efficiency was also investigated, the results showing a similar pattern to 
the COD removal profile with an average TOC removal in the PMASR of 69% observed 
during an OLR of 1.86 kg COD.m-3.d-1 in the UASR (Figure 5). The results indicate that a 
substantial amount of COD that remained in the UASR effluent could be removed 
aerobically by the PMASR. Furthermore, the results also signify that the pharmaceutical 
wastewater can be treated aerobically, and the combined UASR-PMASR system was 
successful in treating the pharmaceutical wastewater with typical total COD removal 
(Figure 8) in the range of 87-90% (when the UASR was operated at OLR 1.86 kg COD. 
m-3.d-1) and 70–80% (when the UASR was operated at OLR 2.48–3.73 kg COD.m-3.d-1). 
  The above results are comparable with Zhou et al. (2006) who reported around 73–90% 
COD removal in the aerobic and up to 97.8% removal in the combined anaerobic-aerobic 
treatment of pharmaceutical wastewater containing Ampicillin and Aureomycin antibiotics. 
Arslan-Alaton et al. (2004) reported 71% COD removal in the activated sludge treatment of 
Penicillin formulation effluent.  
 
3.3 Tylosin reduction 
Incomplete degradation of pharmaceuticals, especially antibiotics in wastewater treatment 
plants could be a contributing factor to the presence of antibiotics in receiving  
surface waters (Al-Ahmad et al. 1999). Because of their bacterial toxicity, antibiotics may 
play a key role in decreasing COD removal rates and their removal from pharmaceutical 
wastewater before discharge to sewer is at least as important as the overall removal of the 
COD fraction.  In this study, Tylosin concentration in the pharmaceutical wastewater feed 
varied from 10 to 220 mg.L-1 and Figure 7 shows the Tylosin degradation profile 
throughout the experimental study in the UASR. Tylosin removal efficiency fluctuated  
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Figure 5: COD and TOC reduction profile of PMASR at different UASR organic loadings. 
 
Figure 6: Specific degradation rate (SDR) profile of PMASR at different UASR organic loadings. 
 
from 70–88% at OLR 1.86 kg COD.m-3.d-1, however, the removal efficiency remained 
relatively constant (93–99%) at OLR 2.48 - 3.73 kg COD.m-3.d-1. Similar removal trend 
was also observed when the reactor OLR was reduced to 1.86 kg COD m-1 d-1 (Figure 7), 
with an average Tylosin concentration in the treated wastewater of 3 mg.L-1 for the all OLR 
investigated (Table 4). This confirms that Tylosin was readily degraded in the reactor under 
anaerobic conditions. In contrast to the COD removal profile, which showed reducing COD 
removal efficiency with increasing OLR, Tylosin concentration remained relatively 
constant in the reactor effluent throughout the experiment. These results are consistent with 
the view that typical wastewater concentrations of Tylosin have a relatively minor influence 
on the overall COD removal efficiency of UASR and do not inhibit substantially the 
activity of methanogenic populations. This result agrees with the study by Poels et al. (1984) 
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on effect of Tylosin on anaerobic digestion, which concluded that at concentration of 50 to 
100 mg.L-1, Tylosin had no inhibitory effect on methane production. Masse et al. (2000) 
reported that presence of Tylosin (110 mg.kg-1 in feed diets) did not effect the treatment of 
swine manure slurry in sequencing batch reactor (SBR). Kolz et al. (2005) showed that 
Tylosin can be reduced up to 90% in an anaerobic batch degradation of swine manure 
slurries with initial concentration of 195 mg.L-1. However, they found that some residual 
Tylosin remained in the slurry after eight months of incubation, indicating incomplete 
degradation. More recently, Angenent et al. (2008) demonstrated that Tylosin with an 
average concentration of 1.6 mg/L in a swine waste can be degraded in a high-rate 
anaerobic digester (ASBR). 
 
OLR (kg COD.m-3.d-1) 
 
Figure 7: Tylosin reduction profile of UASR at different OLR. 
 
Figure 8:Total COD and Tylosin reduction profile of the combined treatment of UASR-PMASR. 
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Table 4: Summary of treatment performance of the pharmaceutical wastewater by UASR-PMASR 
(average values when reactor approached steady-state). 
Parameter         Raw       UASR          PMASR   UASR-PMASR        
COD (mg.L-1)   7450  2000           700   –               
COD removal (%)        –       73*            66*  89*           
Tylosin (mg.L-1)         < 200          3                 2.7  –                              
Tylosin reduction (%)    –                 95               10  97                           
*at UASR OLR 1.86 kg COD.m-3.d-1. 
 
  One essential point to consider is whether Tylosin removal from the UASR system was 
caused by sorption (adsorption to reactor sludge solids) or anaerobic degradation. Previous 
work on anaerobic degradation of Tylosin did not clearly state the reason for Tylosin 
disappearance. Loke et al. (2000) reported that the loss of Tylosin in batch anaerobic 
degradation experiments of pig manure was caused by a combination of sorption, abiotic 
transformation (e.g. hydrolysis) and biotic transformation (biodegradation); however, no 
further details were examined. Kolz et al. (2005) also showed that Tylosin disappearance in 
batch anaerobic degradation experiments of swine manure slurries was caused by abiotic 
and biotic degradation, but suggested strong sorption to slurry solids to be the main 
mechanism of Tylosin loss. Consequently, the loss of Tylosin in UASR system could be 
combination of sorption to sludge solids, abiotic and biotic degradation.  
  Feed to the PMASR contains an average Tylosin of 3 mg.L-1 (effluent from UASR) and 
Figure 8 shows the Tylosin reduction in the combined UASR-PMASR system. The results 
showed that, an average Tylosin reduction for the combined system was 97% (Table 4) for 
the entire duration of the experiment, with the PMASR effluent having an average Tylosin 
value of 2.7 mg.L-1 (plot of Tylosin removal in PMASR not presented). This result 
indicates that a small quantity of Tylosin was reduced (around 10% or 0.3 mg.L-1) in the 
PMASR, since the majority of it was reduced in UASR (Table 4). Therefore, these results 
indicate that the aerobic reactor was not particularly effective in degrading Tylosin at the 
low starting concentrations that were applied experimentally. A similar observation was 
also reported by Zhou et al. (2006) when treating pharmaceutical wastewater containing 
Ampicillin and Aureomycin antibiotics in a combined anaerobic-aerobic reactor systems. 
Although the COD removal was high in the aerobic system (up to 90%), the removal 
efficiencies of the two antibiotics were less than 10%. 
 
4. Conclusions  
This study has demonstrated that the combination UASR-PMASR treatment system was 
effective in removing organic matter in pharmaceutical wastewater containing Tylosin. An 
average COD reduction of 73% at a HRT of 4 d and OLR of 1.86 kg COD.m-3.d-1 was 
achieved in the UASR, confirmed the biomass in the anaerobic reactor had acclimated to 
the antibiotic. Under these conditions, an average of 95% Tylosin reduction was achieved 
in the, indicated that this antibiotic could be degraded efficiently in the anaerobic reactor 
system. It was anticipated that as OLR was increased (2.48–3.73 kg COD.m-3.d-1) the 
increasing levels of Tylosin in the reactor feed would influence the microbial populations 
of the sludge, and therefore cause a detrimental effect on UASR treatment efficiency. 
However, this was not observed at levels of Tylosin typically present in the pharmaceutical 
wastewater (10–220 mg.L-1). Further polishing of UASR effluent by a PMASR showed 
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successful treatment of residual COD in the effluent. Around 1300 mg.L-1 COD was 
removed in PMASR, giving a typical effluent COD of 700 mg.L-1 when the UASR OLR 
was 1.86 kg COD.m-3.d-1. In contrast, a small quantity of Tylosin was reduced (around 10% 
or 0.3 mg.L-1) in the PMASR, showed that the aerobic reactor was not particularly effective 
in degrading Tylosin at the concentrations applied. 
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